|
Market Cap (5-Jun) $102,067,456 (1,050th) |
Close (30-Jun) $0.062 |
Volume (30-Jun) 526,676 |
Shortsold (26-May) 683,172 (0.11%) (444th) |
|
52w High $0.67 |
52w Low $0.165 |
P/E 10.78 |
EPS -0.03 |
DXB released this announcement to the ASX on 4 July 2022, 8:40. The announcement is marked as price sensitive, and is 4 page(s) in length and 358.13kb in size.
You can view all announcements from DXB and see how they appear on a price chart on the announcements page.
At the date of this announcement, DXB was 0.058% short sold according to ASIC data. It was ranked the 509th most shorted stock on the ASX. It is now ranked as the 444th most shorted stock on the ASX with 0.114% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from DXB | |
|---|---|
| Application for quotation of securities - DXB | 29 June 2023, 9:01 |
| Application for quotation of securities - DXB | 29 June 2023, 9:00 |
| Application for quotation of securities - DXB | 29 June 2023, 8:59 |
| DMX-700 Study Shows Significant 80% Reduction in Lung Injury | 4 July 2022, 8:40 |
| REMAP-CAP COVID-19 Study Analysis Update | 27 June 2022, 8:36 |
| New Clinical Trial for DMX-200 in Diabetic Kidney Disease | 7 June 2022, 8:59 |
| Dimerix to Present at BIO International Convention | 6 June 2022, 8:59 |
You must be logged in to post a reply.
Dimerix 